Rachelle L. Dillon

1.0k total citations
18 papers, 821 citations indexed

About

Rachelle L. Dillon is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rachelle L. Dillon has authored 18 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rachelle L. Dillon's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Rachelle L. Dillon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Rachelle L. Dillon collaborates with scholars based in Canada, United States and Russia. Rachelle L. Dillon's co-authors include William J. Muller, Donald E. White, Bryan T. Hennessy, Gordon B. Mills, James R. Woodgett, Richard Marcotte, Michael Mowat, Juan Palazzo, Saundra M. Ehrlich and Feig Sa and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Oncogene.

In The Last Decade

Rachelle L. Dillon

18 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachelle L. Dillon Canada 11 539 256 158 97 93 18 821
Morihisa Akagi Japan 15 336 0.6× 255 1.0× 142 0.9× 78 0.8× 75 0.8× 22 699
Eric D. Slosberg United States 14 392 0.7× 182 0.7× 103 0.7× 100 1.0× 55 0.6× 29 654
Yu Zheng China 22 697 1.3× 278 1.1× 160 1.0× 112 1.2× 29 0.3× 48 1.2k
Kanika A. Bowen United States 12 647 1.2× 288 1.1× 221 1.4× 42 0.4× 35 0.4× 15 943
Omar Moussa United States 19 423 0.8× 140 0.5× 203 1.3× 108 1.1× 88 0.9× 25 828
Gabriella Cirmena Italy 18 383 0.7× 188 0.7× 229 1.4× 35 0.4× 71 0.8× 41 813
Huiying Zhi United States 12 372 0.7× 127 0.5× 119 0.8× 77 0.8× 67 0.7× 20 684
Scott Wise United States 17 660 1.2× 293 1.1× 161 1.0× 157 1.6× 47 0.5× 43 1.2k
Lindsey N. Jackson United States 15 473 0.9× 210 0.8× 126 0.8× 72 0.7× 28 0.3× 19 856
Stacy A. Blaine United States 11 452 0.8× 243 0.9× 181 1.1× 75 0.8× 85 0.9× 11 739

Countries citing papers authored by Rachelle L. Dillon

Since Specialization
Citations

This map shows the geographic impact of Rachelle L. Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachelle L. Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachelle L. Dillon more than expected).

Fields of papers citing papers by Rachelle L. Dillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachelle L. Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachelle L. Dillon. The network helps show where Rachelle L. Dillon may publish in the future.

Co-authorship network of co-authors of Rachelle L. Dillon

This figure shows the co-authorship network connecting the top 25 collaborators of Rachelle L. Dillon. A scholar is included among the top collaborators of Rachelle L. Dillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachelle L. Dillon. Rachelle L. Dillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
O’Donnell, Michael A., Neal D. Shore, Thomas E. Keane, et al.. (2021). MP16-03 PHASE 3 STUDY OF VICINEUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: 24-MONTH RESULTS. The Journal of Urology. 206(Supplement 3). 3 indexed citations
3.
Shore, Neal D., Michael A. O’Donnell, Thomas E. Keane, et al.. (2020). PD03-02 PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER. The Journal of Urology. 203(Supplement 4). 26 indexed citations
4.
Basak, Pratima, et al.. (2017). In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors. Genes Chromosomes and Cancer. 57(4). 182–191. 14 indexed citations
5.
Dillon, Rachelle L., et al.. (2017). Abstract 79: Trastuzumab and C6.5 diabody armed with deBouganin overcome drug resistance to ADCs comprised of anti-microtubule agents. Cancer Research. 77(13_Supplement). 79–79. 1 indexed citations
6.
Dillon, Rachelle L., et al.. (2017). Abstract 614: VB4-845 tumor cell killing in a combination study with the anti-PD-1, Nivolumab. Cancer Research. 77(13_Supplement). 614–614. 2 indexed citations
7.
Dillon, Rachelle L., et al.. (2016). Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance. Journal of Immunotherapy. 39(3). 117–126. 19 indexed citations
8.
Sabbir, Mohammad Golam, Rachelle L. Dillon, & Michael Mowat. (2016). Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation. Biology Open. 5(4). 452–460. 19 indexed citations
9.
Dillon, Rachelle L., et al.. (2016). DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents. Molecules. 21(12). 1741–1741. 8 indexed citations
10.
Patterson, Andrea M., Saghar Kaabinejadian, Curtis McMurtrey, et al.. (2015). Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. Molecular Cancer Therapeutics. 15(2). 313–322. 5 indexed citations
11.
12.
Dillon, Rachelle L. & William J. Muller. (2010). Distinct Biological Roles for the Akt Family in Mammary Tumor Progression. Cancer Research. 70(11). 4260–4264. 128 indexed citations
13.
Oldenhuis, Corina N.A.M., Pankaj Bhargava, Walter J. Loos, et al.. (2010). 370 A phase Ib study of escalating doses of Vascular Endothelial Growth Factor (VEGF) tyrosine kinase inhibitor Tivozanib and FOLFOX6 in patients with advanced gastrointestinal (GI) tumors. European Journal of Cancer Supplements. 8(7). 117–117. 1 indexed citations
14.
Dillon, Rachelle L., Richard Marcotte, Bryan T. Hennessy, et al.. (2009). Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression. Cancer Research. 69(12). 5057–5064. 148 indexed citations
15.
16.
Dillon, Rachelle L., Donald E. White, & William J. Muller. (2007). The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene. 26(9). 1338–1345. 240 indexed citations
17.
Howe, Louise R., Rachelle L. Dillon, Lawrence J.T. Young, et al.. (2005). HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice. Cancer Research. 65(21). 10113–10119. 114 indexed citations
18.
Conant, Emily F., Rachelle L. Dillon, Juan Palazzo, Saundra M. Ehrlich, & Feig Sa. (1994). Imaging findings in mucin-containing carcinomas of the breast: correlation with pathologic features.. American Journal of Roentgenology. 163(4). 821–824. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morihisa Akagi Breakdown of academic impact, for papers by Eric D. Slosberg Breakdown of academic impact, for papers by Yu Zheng Breakdown of academic impact, for papers by Kanika A. Bowen Breakdown of academic impact, for papers by Omar Moussa Breakdown of academic impact, for papers by Gabriella Cirmena Breakdown of academic impact, for papers by Huiying Zhi Breakdown of academic impact, for papers by Scott Wise Breakdown of academic impact, for papers by Lindsey N. Jackson Breakdown of academic impact, for papers by Stacy A. Blaine
Rankless by CCL
2026